NVDX3

DRUG4 trials

Sponsors

Novadip Biosciences

Conditions

Degenerative Lumbar SpondylolisthesisDistal Radius FracturesDistal Radius fractureLow grade degenerative lumbar spondylolisthesis by interbody spine fusion

Phase 1

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Active, not recruitingNCT05961956

Novadip BiosciencesDegenerative Lumbar Spondylolisthesis

Start: 2023-10-12End: 2026-04-18Updated: 2025-12-24

Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.

CompletedNCT05987033

Novadip BiosciencesDistal Radius Fractures

Start: 2023-08-08End: 2024-12-19Updated: 2026-01-28

Long-term safety bucket trial with NVDX3, an osteogenic implant of human allogenic origin

RecruitingCTIS2024-511661-11-01

Novadip BiosciencesDistal Radius fracture, Low grade degenerative lumbar spondylolisthesis by interbody spine fusion

Start: 2024-08-22Target: 20Updated: 2025-09-02

Long-term Safety Trial with NVDX3

RecruitingNCT06532253

Novadip BiosciencesDegenerative Lumbar Spondylolisthesis, Distal Radius Fractures

Start: 2024-08-22End: 2036-03-31Target: 15Updated: 2024-09-05